Demographic variables | N or X | % |
---|---|---|
Gender | ||
Female | 8 | 25.0 |
Male | 24 | 75.0 |
Age (year) | 73.50 (52-94) | 73.43 ± 10.14 |
50-59 | 4 | 12.5 |
60-79 | 16 | 50.0 |
≥ 80 | 12 | 37.5 |
BMI | ||
Female | 28.89 (20.41-44.44) | |
Male | 27.68 (20.76-44.98) | |
Smoking status | ||
Female | 2 | 25.0 |
Male | 14 | 58.33 |
Specimen | Fungal isolate | % |
---|---|---|
Blood | 16 | 23.2 |
Aspirate | 12 | 17.4 |
Urine | 29 | 42.1 |
Urine + blood | 8 | 11.6 |
Aspirate + blood | 3 | 4.4 |
Aspirate + urine | 1 | 1.3 |
Fungus types | Fungal isolate | Blood | Tracheal aspirate | Urine |
---|---|---|---|---|
Total: 16 | Total: 12 | Total: 29 | ||
20 (35.08) | 5 (31.25) | 4 (33.33) | 11 (37.93) | |
18 (31.58) | 4 (25.00) | 0 (0.00) | 14 (48.27) | |
14 (24.56) | 7(43.75) | 3 (25) | 4 (13.79) | |
3 (5.28) | 0 (0.00) | 3 (25) | 0 (0.00) | |
1 (1.75) | 0 (0.00) | 1 (8.34) | 0 (0.00) | |
1 (1.75) | 0 (0.00) | 1 (8.34) | 0 (0.00) |
Mean ± SD | N | N (%) |
---|---|---|
1-30days | 4 | 25 |
> 30 days | 12 | 75 |
Used antibiotics groups | Number of patients | Days of using antibiotic before fungal infection |
---|---|---|
Carbapenem | 32 (100%) | 17 ± 12.52 |
Glycopeptide | 32 (100%) | 13 ± 7.4 |
Linezolid | 23 (71.87%) | 10 ± 7.30 |
Quinolone | 11 (33.3%) | 14 ± 7.20 |
Tigecycline | 8 (24.24%) | 12 ± 5 |
Aminoglycoside | 2 (6.06%) | 10 ± 2.3 |
Accompanying disease | Number of patients |
---|---|
Diabetes mellitus | 11 (34.4) |
Cardiovascular disease | 22 (68.8) |
Respiratory disease | 6 (18.8) |
Neurological disease | 11 (34.4) |
Renal disease | 1 (3.1) |
Number of Patients | Fungal Isolate | |
---|---|---|
Parenteral nutrition | ||
No | 25 (78.1) | 45 (78.95) |
Yes | 7 (21.9) | 12 (21.05) |
Steroid use | ||
No | 20 (62.5) | 44 (77.19) |
Yes | 12 (37.5) | 13 (22.81) |
ICU insulin use | ||
No | 12 (37.5) | 24 (42.11) |
Yes | 20 (62.5) | 33 (57.89) |
Central venous catheter | ||
No | 14 (43.75) | 45 (78.95) |
Yes | 18 (56.25) | 12 (21.05) |